CJ
C2N JMK, Inc.
SEC filingBiotechnology · St. Louis, MO
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise2count reported to the SEC
FiledAug 6, 2025first sale May 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jinzhu YuExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.